Skip to main content
Erschienen in: Journal of Cancer Survivorship 4/2022

14.06.2021 | COVID-19 Zur Zeit gratis

“Every day is just kind of weighing my options.” Perspectives of young adult cancer survivors dealing with the uncertainty of the COVID-19 global pandemic

verfasst von: L. Aubree Shay, Marlyn Allicock, Amanda Li

Erschienen in: Journal of Cancer Survivorship | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We explored adolescent and young adult cancer survivor (AYA) experiences with COVID-19 to understand the impact of living through a pandemic, unmet needs, and coping strategies.

Methods

AYAs were recruited nationally, completed an online survey, and attended one of six online focus groups. We used qualitative content analysis to analyze focus group data.

Results

Thirty-nine AYAs completed the survey, and 24 also participated in the focus groups. In the survey, AYAs responded that COVID-19 increased anxiety about their health or their family’s health, feelings of isolation, and worries about job security. Overarching focus group themes included AYA behavioral responses to the pandemic similar to their peers, the added burden of cancer, and unexpected advantages of a cancer history. When discussing the added burden of cancer, subthemes included difficulties and delays in medical care, mental health stressors, and compounding uncertainty. Unexpected advantages of a cancer history included relying on coping strategies developed during active treatment and resiliency from practicing social distancing during treatment.

Conclusions

AYAs have struggled in the early pandemic in ways similar to their peers but with compounding uncertainty regarding their unknown risk due to cancer history. Healthcare providers and systems can better support AYAs by providing additional psychosocial supports, developing strategies to triage good candidates for telehealth, and providing information about cancer survivor-specific risks for COVID-19.

Implications for Cancer Survivors

Our findings indicate a need for psychosocial supports that address managing anxiety and uncertainty. AYAs may be able to draw on their cancer experiences to navigate the COVID-19 pandemic.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
11.
Zurück zum Zitat Forman J, Damschroder L. Qualitative content analysis. In: Jacoby L & Siminoff LA, editors. Empirical research for bioethics: A primer. 2008:39–62. Forman J, Damschroder L. Qualitative content analysis. In: Jacoby L & Siminoff LA, editors. Empirical research for bioethics: A primer. 2008:39–62.
18.
Zurück zum Zitat Košir U, Loades M, Wild J, Wiedemann M, Krajnc A, Roškar S, et al. The impact of COVID-19 on the cancer care of adolescents and young adults and their well-being: results from an online survey conducted in the early stages of the pandemic. Cancer. 2020;126:4414–22. https://doi.org/10.1002/cncr.33098.CrossRefPubMed Košir U, Loades M, Wild J, Wiedemann M, Krajnc A, Roškar S, et al. The impact of COVID-19 on the cancer care of adolescents and young adults and their well-being: results from an online survey conducted in the early stages of the pandemic. Cancer. 2020;126:4414–22. https://​doi.​org/​10.​1002/​cncr.​33098.CrossRefPubMed
Metadaten
Titel
“Every day is just kind of weighing my options.” Perspectives of young adult cancer survivors dealing with the uncertainty of the COVID-19 global pandemic
verfasst von
L. Aubree Shay
Marlyn Allicock
Amanda Li
Publikationsdatum
14.06.2021
Verlag
Springer US
Schlagwort
COVID-19
Erschienen in
Journal of Cancer Survivorship / Ausgabe 4/2022
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-021-01069-9

Weitere Artikel der Ausgabe 4/2022

Journal of Cancer Survivorship 4/2022 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.